Additional Information for Palivizumab Injection
Palivizumab Injection is a medication that belongs to the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies.
Palivizumab is a monoclonal antibody that is used to prevent serious lung infections caused by respiratory syncytial virus (RSV) in infants and young children at high risk. RSV is a common virus that can cause severe respiratory infections, especially in premature infants, infants with certain heart or lung conditions, and infants with weakened immune systems.
Palivizumab is administered as an injection and works by helping the body's immune system to fight off RSV. It is typically given once a month during the RSV season, which is usually from November to April.
It is important to note that Palivizumab Injection should only be used under the guidance and prescription of a healthcare professional. The dosage and frequency of administration may vary depending on the individual patient's condition and risk factors.
Please consult with a healthcare professional for more information about Palivizumab Injection and its appropriate use.
Related Item Names for INC 67179 Palivizumab Injection
NATO Stock Numbers with Item Name 67179 Palivizumab Injection Page 1 of 1
- SYNAGIS 100 MG INJETAVEL
- RNCC: 3 | RNVC: 2 | DAC: 3
- 7891158038679
- RNCC: 3 | RNVC: 2 | DAC: U